Federation des caisses Desjardins du Quebec’s Moderna MRNA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $676K | Sell |
24,490
-7,021
| -22% | -$194K | ﹤0.01% | 968 |
|
2025
Q1 | $893K | Buy |
31,511
+166
| +0.5% | +$4.71K | ﹤0.01% | 858 |
|
2024
Q4 | $1.3M | Buy |
31,345
+276
| +0.9% | +$11.5K | 0.01% | 734 |
|
2024
Q3 | $2.08M | Buy |
31,069
+682
| +2% | +$45.6K | 0.01% | 572 |
|
2024
Q2 | $3.61M | Sell |
30,387
-2,013
| -6% | -$239K | 0.02% | 401 |
|
2024
Q1 | $3.32M | Buy |
32,400
+808
| +3% | +$82.8K | 0.02% | 398 |
|
2023
Q4 | $3.14M | Sell |
31,592
-358
| -1% | -$35.6K | 0.03% | 342 |
|
2023
Q3 | $3.3M | Sell |
31,950
-4,493
| -12% | -$464K | 0.03% | 331 |
|
2023
Q2 | $4.43M | Sell |
36,443
-10,492
| -22% | -$1.27M | 0.04% | 303 |
|
2023
Q1 | $7.21M | Buy |
46,935
+1,344
| +3% | +$206K | 0.08% | 198 |
|
2022
Q4 | $8.19M | Sell |
45,591
-5,627
| -11% | -$1.01M | 0.1% | 171 |
|
2022
Q3 | $6.06M | Buy |
51,218
+595
| +1% | +$70.4K | 0.07% | 206 |
|
2022
Q2 | $7.23M | Buy |
50,623
+3,598
| +8% | +$514K | 0.08% | 191 |
|
2022
Q1 | $8.1M | Buy |
47,025
+2,034
| +5% | +$350K | 0.08% | 199 |
|
2021
Q4 | $11.4M | Sell |
44,991
-1,044
| -2% | -$265K | 0.11% | 158 |
|
2021
Q3 | $17.7M | Buy |
46,035
+3,257
| +8% | +$1.25M | 0.18% | 107 |
|
2021
Q2 | $10M | Sell |
42,778
-8,498
| -17% | -$1.99M | 0.1% | 168 |
|
2021
Q1 | $6.72M | Sell |
51,276
-4,355
| -8% | -$571K | 0.07% | 213 |
|
2020
Q4 | $5.81M | Buy |
55,631
+53,220
| +2,207% | +$5.56M | 0.07% | 235 |
|
2020
Q3 | $171K | Buy |
2,411
+1,186
| +97% | +$83.9K | ﹤0.01% | 913 |
|
2020
Q2 | $78.7K | Buy |
1,225
+1,075
| +717% | +$69K | ﹤0.01% | 1098 |
|
2020
Q1 | $4.49K | Buy |
+150
| New | +$4.49K | ﹤0.01% | 1845 |
|